Applied chronically, SSRIs lead to desensitization of presynaptic 5-HT1A receptors that weakens the inhibitory effect of these receptors on the 5-HT system, thereby increasing its functional activity and ameliorating depression [26]. The gene discussed is HTR1A; the disease is depressive disorder.